13D Filing: Versartis Inc. (NASDAQ:VSAR) and Sofinnova Venture Partners Viii

Page 8 of 12

Page 8 of 12 – SEC Filing

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

On September
30, 2013, SVP VIII entered into an Agreement of Purchase and Sale pursuant to which SVP VIII acquired from a stockholder of the
Issuer an aggregate 269,136 shares of Series B Convertible Preferred Stock for a purchase price of $0.35 per share, or $94,197.60
in the aggregate.

On October
1, 2013, SVP VIII entered into a Series D Preferred Stock Purchase Agreement pursuant to which SVP VIII acquired from the Issuer
an aggregate 8,916,123 shares of Series D-1 Convertible Preferred Stock for a purchase price of $0.5625 per share, or $5,015,319
in the aggregate, and subsequently 9,229,853 shares of Series D-2 Convertible Preferred Stock for a purchase price of $0.7594 per
share, or $7,009,150 in the aggregate.

On February
14, 2014, SVP VIII entered into a Series E Preferred Stock Purchase Agreement pursuant to which SVP VIII acquired from the Issuer
an aggregate 5,585,144 shares of Series E Convertible Preferred Stock for a purchase price of $1.128 per share, or $6,300,042 in
the aggregate.

In connection with the
Issuer’s initial public offering of Common Stock, which closed on March 26, 2014 (“Offering”), the shares of
Series B Convertible Preferred Stock previously acquired by SVP VIII were converted into Common Stock on a 1 for 11.5 basis.

In connection with the
Offering, the shares of Series D-1 Convertible Preferred Stock previously acquired by SVP VIII were converted into Common Stock
on a 1 for 11.5 basis.

In connection with the
Offering, the shares of Series D-2 Convertible Preferred Stock previously acquired by SVP VIII were converted into Common Stock
on a 1 for 11.5 basis.

In connection with the
Offering, the shares of Series E Convertible Preferred Stock previously acquired by SVP VIII were converted into Common Stock on
a 1 for 11.5 basis.

SVP VIII purchased 60,000 shares of the Common Stock at $21.00
per share in the Offering, or $1,260,000 in the aggregate.

On January 21, 2015 SVP VIII purchased 215,000 shares of Common
Stock in a secondary offering offered by Issuer pursuant to a Registration Statement on Form S-1 at the offering price of $17.25
per share, or $3,708,750 in the aggregate.

On February 24, 2017, SVP VIII disposed of 60,000 shares of
Common Stock in open market sales for an average price of $21.984 per share or $1,319,040 in the aggregate.

On February 27, 2017, SVP VIII disposed of 75,000 shares of
Common Stock in open market sales for an average price of $23.0295 per share or $1,727,213 in the aggregate.

On February 28, 2017, SVP VIII disposed of 1,000 shares of Common
Stock in open market sales for an average price of $22.05 per share or $22,050 in the aggregate.

On March 1, 2017, SVP VIII disposed of 15,882 shares of Common
Stock in open market sales for an average price of $22.3015 per share or $354,192 in the aggregate.

On March 2, 2017, SVP VIII disposed of 33,279 shares of Common
Stock in open market sales for an average price of $22.0601 per share or $734,138 in the aggregate.

Follow Aravive Inc. (NASDAQ:ARAV)

Page 8 of 12